iShares US Pharmaceuticals ETF
IHE
IHE
143 hedge funds and large institutions have $374M invested in iShares US Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $387M → $374M (-$12.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
143
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.52M | |
| 2 | +$2.75M | |
| 3 | +$1.65M | |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$839K |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$584K |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$12.9M | |
| 3 | -$6.27M | |
| 4 |
RCM
Raleigh Capital Management
Cary,
North Carolina
|
-$2.07M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.33M |